| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.24 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |